240 Participants Needed

Cognitive Behavioral Therapy for Chronic Pelvic Pain Syndrome

(EPPIC Trial)

Recruiting at 3 trial locations
RF
JL
PO
Overseen ByPatricia O'Leary, EdM
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: State University of New York at Buffalo
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new, short version of cognitive behavioral therapy (CBT) to help individuals with chronic pelvic pain syndrome improve their well-being. CBT teaches ways to manage pain and other symptoms affecting daily life. The study compares this therapy to educational support to determine which is more effective. Individuals who have experienced moderate pelvic pain for at least six months, impacting their daily activities, might be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to explore innovative therapy options that could significantly enhance quality of life.

Do I need to stop my current medications to join the trial?

You don't have to stop your current medications, but you should not start any new ones until after the initial 2-week pre-treatment baseline period, unless it's medically necessary.

What prior data suggests that this cognitive behavioral therapy is safe for treating chronic pelvic pain syndrome?

Research has shown that Cognitive Behavioral Therapy (CBT) is generally safe for treating long-term pain, including chronic pelvic pain. CBT helps individuals manage pain using practical techniques. Studies have found that CBT can effectively address chronic pain without causing major side effects.

One study demonstrated that combining CBT with regular care reduced pain and improved function over time. Another study confirmed that CBT is effective for chronic pain and is generally safe, with most individuals tolerating it well and few reports of serious problems.

Overall, Minimal Contact-Cognitive Behavior Therapy (MC-CBT) appears to be a safe choice for those with chronic pelvic pain. It focuses on teaching skills to manage pain and improve quality of life.12345

Why are researchers excited about this trial?

Researchers are excited about Minimal Contact-Cognitive Behavior Therapy for chronic pelvic pain syndrome because it offers a fresh approach by focusing on teaching patients practical self-management tools. Unlike typical treatments that often rely on medication to relieve pain and urinary symptoms, this therapy targets the biobehavioral factors that can worsen these symptoms. This method empowers patients to actively manage their condition, potentially leading to long-term relief without the side effects associated with standard pharmaceutical options.

What evidence suggests that this trial's treatments could be effective for chronic pelvic pain syndrome?

Research shows that Cognitive Behavioral Therapy (CBT) effectively treats chronic pelvic pain, including urologic chronic pain syndrome (UCPPS). In this trial, participants may receive Minimal Contact-Cognitive Behavior Therapy, which teaches practical tools and strategies for self-care to manage pain. Strong evidence supports CBT, with over 20 reviews and analyses confirming its benefits for chronic pain. Although the exact mechanisms remain unclear, patients often experience reduced pain and fewer related symptoms. Overall, CBT focuses on the interaction between the body and mind in worsening pelvic pain, making it a promising option for many.12678

Who Is on the Research Team?

JL

Jeffrey Lackner, PsyD

Principal Investigator

University at Buffalo (SUNY)

Are You a Good Fit for This Trial?

The EPPIC study is for adults aged 18-70 with a doctor-confirmed diagnosis of chronic pelvic pain syndromes like interstitial cystitis or chronic prostatitis. Participants must have had pelvic pain for at least six months, be willing to attend therapy sessions, and not start new medications during the initial study period.

Inclusion Criteria

My gender, race, or ethnicity does not limit my participation.
I have been diagnosed with IC/BPS or CP/CPPS by a specialist.
I understand the study and can give my consent.
See 11 more

Exclusion Criteria

I do not have any health conditions that would make it unsafe for me to participate in this study.
I have a neurological condition like MS that affects my bladder.
Has a major psychiatric disorder which would impede conduct of the clinical study
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 4-session cognitive behavioral therapy or education/support control over a 10-week acute phase

10 weeks
4 sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months
Assessments at 3 and 6 months post-treatment

What Are the Treatments Tested in This Trial?

Interventions

  • Minimal Contact-Cognitive Behavior Therapy
  • Patient Education/Support
Trial Overview This trial tests an ultra-brief cognitive behavioral therapy (CBT) designed to treat various urologic chronic pain syndromes. It involves four sessions aimed at easing dissemination and reducing treatment complexity compared to existing therapies.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Minimal Contact-Cognitive Behavior TherapyExperimental Treatment1 Intervention
Group II: Education/SupportActive Control1 Intervention

Minimal Contact-Cognitive Behavior Therapy is already approved in United States for the following indications:

🇺🇸
Approved in United States as Cognitive Behavioral Therapy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

State University of New York at Buffalo

Lead Sponsor

Trials
279
Recruited
52,600+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

University of California, Los Angeles

Collaborator

Trials
1,594
Recruited
10,430,000+

Published Research Related to This Trial

Cognitive-behavioral therapy (CBT) is an effective first-line treatment for chronic pain, supported by numerous randomized controlled trials showing improvements in pain and related issues across various chronic pain syndromes.
Recent innovations in CBT delivery, such as web-based and telephone formats, have expanded its accessibility and effectiveness for diverse populations, including children and older adults, indicating a promising direction for future treatment approaches.
Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research.Ehde, DM., Dillworth, TM., Turner, JA.[2022]
A 6-week intervention combining patient-centered graded exposure therapy with manual therapy significantly improved fear-avoidance behavior and physical functioning in women with chronic pelvic pain, compared to manual therapy alone.
The study involved 49 women and showed that the combined approach not only provided immediate benefits but also maintained improvements in outcomes at a 3-month follow-up, highlighting its long-term efficacy.
Effects of a Patient-Centered Graded Exposure Intervention Added to Manual Therapy for Women With Chronic Pelvic Pain: A Randomized Controlled Trial.Ariza-Mateos, MJ., Cabrera-Martos, I., Ortiz-Rubio, A., et al.[2019]
The RESOLVE trial is a large-scale, 3-arm randomized control trial designed to compare the effectiveness of telephonic/video and online CBT for chronic pain against usual care, involving diverse populations across urban and rural areas.
This study aims to assess not only the clinical effectiveness of these CBT interventions in reducing pain severity but also their cost-effectiveness, potentially improving access to treatment for underserved populations.
Comparing the clinical and cost-effectiveness of remote (telehealth and online) cognitive behavioral therapy-based treatments for high-impact chronic pain relative to usual care: study protocol for the RESOLVE multisite randomized control trial.Mayhew, M., Balderson, BH., Cook, AJ., et al.[2023]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38228093/
Cognitive Behavioral Therapy for Chronic Pelvic Pain - PubMedResults: While evidence supports CBT for treatment-refractory chronic pain disorders, there is limited understanding of why or how CBT might work, for whom it ...
Study protocol and methods for Easing Pelvic Pain ...A clinical trial examining the efficacy of low-intensity cognitive behavioral therapy (Minimal Contact CBT or MC-CBT) for UCPPS and its durability 3 and 6 ...
Cognitive behavioral therapy for the treatment of chronic ...Evidence suggests CBT is beneficial in treating chronic pelvic pain (CPP) patients · Treating the underlying etiology of the CPP is beneficial and may have an ...
Cognitive Behavioral Therapy for Chronic Pelvic PainEmpirical support for CBT as a self-management treatment for chronic pain is based on well over 20 systematic reviews. Meta-analyses generally ...
results of a non-randomised controlled feasibility trial - PMCPhysiotherapy and combined cognitive-behavioural therapy for patients with chronic pelvic pain syndrome: results of a non-randomised controlled ...
Barriers and Facilitators of Evidence-Based ...EBPs with demonstrated effectiveness for improving chronic pain outcomes include cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), ...
Non-pharmacological therapies for treating chronic pelvic...A 1-year follow-up study indicated that CBT combined with gynecologic care could reduce psychological symptoms, pain, and related dysfunction in ...
Cognitive Behavioral Therapy for the Treatment of Chronic ...[7] Cognitive behavioral therapy (CBT), a psychotherapy for CPP in women, is effective and widely used in treating chronic pain conditions (SOGC ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security